Paasa Logo
Jiangsu Recbio Technology Co., Ltd. logo
2179HKSEMarket closedOpens 9:30am HKT

Jiangsu Recbio Technology Co., Ltd.

HK$4.40Last updated
+HK$0.00 (0.00%)Past day
Timezone
No price history for this range.

Jiangsu Recbio Technology Co., Ltd. (HKSE: 2179) is trading at HK$4.40, about ₹54 at today's HKD/INR rate, as of 27 Sep 2026, 10:52 PM ET. Indian residents can buy Jiangsu Recbio Technology from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:HK$4.40
Previous close:HK$4.40
Volume:500.00

Today's low

HK$4.40

Today's high

HK$4.40

52 week low

HK$3.40

52 week high

HK$7.57

2179 opened at HK$4.40, closed previously at HK$4.40, and has traded between HK$3.40 and HK$7.57 over the past 52 weeks.

About

Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company primarily engaged in the pioneering research, development, and eventual market introduction of subunit vaccines throughout the People's Republic of China. A significant portion of its pipeline is dedicated to combating human papillomavirus (HPV)-related diseases, including cervical cancer and genital warts. Its most advanced candidate, REC603, is a recombinant 9-valent HPV vaccine currently undergoing Phase III clinical trials. Additionally, two bivalent HPV vaccines, REC601 and REC602, are progressing through Phase I trials. Further early-stage development includes the quadrivalent REC604a and 9-valent REC604b recombinant HPV vaccines, both in preclinical stages. Beyond HPV, the company boasts a diverse pipeline addressing other infectious diseases. Its COVID-19 efforts include ReCOV, a recombinant vaccine candidate in Phase II/III trials, and the preclinical messenger RNA (mRNA) candidate, R520A. Other preclinical projects target various conditions, such as the recombinant shingles vaccine REC610, the virus-vectored adult tuberculosis vaccine REC607, and its recombinant counterpart REC606. Also in preclinical development are the recombinant quadrivalent influenza vaccine REC617 and the recombinant quadrivalent hand-foot-mouth disease vaccine REC605. Established in 2011, Recbio Technology maintains its headquarters in Taizhou, People's Republic of China.

Country
CN
CEO
Yong Liu
Exchange listed on
HKSE
Industry
Biotechnology
Base currency
HKD
Full Time Employees
491
Sector
Healthcare
IPO date
31/03/2022

Key statistics

Avg. volume

16.47K

Market cap

HK$2.33B

P/E Ratio

-4.89

Price-to-sales ratio

214.69

Enterprise value

CN¥2.48B

Free cash flow yield

-25.33%

Debt-to-equity ratio

1.35

Return on equity

-79.24%

ROIC

-37.50%

Beta

0.08

Dividend yield

0.00%

Last dividend

HK$0.00

Financial overview

Revenue

CN¥12.40M

Earnings per share

-CN¥1.12

Free cash flow

-CN¥601.50M

Net profit margin

-5134.34%

Gross margin

-509.44%

EBITDA

-CN¥486.44M

Revenue growth

-54.10%

Similar securities

This is not an investment recommendation

How to buy Jiangsu Recbio Technology from India

Indian residents can buy Jiangsu Recbio Technology shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.

  3. Search for Jiangsu Recbio Technology and place an order

    Find Jiangsu Recbio Technology by name or by its ticker, 2179, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Jiangsu Recbio Technology trades 7:00 am – 1:30 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Jiangsu Recbio Technology position in HKD and INR. Jiangsu Recbio Technology pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Jiangsu Recbio Technology from India

Trading and taxes when buying Jiangsu Recbio Technology from India

Trading and limits

Trading hours
9:30 am – 4:00 pm HKT
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneJiangsu Recbio Technology does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Jiangsu Recbio Technology stock?

Yes. Jiangsu Recbio Technology (2179) has been listed on the Hong Kong Stock Exchange since 2022, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Jiangsu Recbio Technology share cost in rupees?

One Jiangsu Recbio Technology share is HK$4.40 — about ₹54 at an HKD/INR rate of 12.25 on 28 Sep 2026. Both the Jiangsu Recbio Technology price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Jiangsu Recbio Technology from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Jiangsu Recbio Technology?

Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.

How are gains on Jiangsu Recbio Technology shares taxed in India?

Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Jiangsu Recbio Technology price. Paasa issues a capital-gains statement for your return.

Does Jiangsu Recbio Technology pay a dividend?

No. Jiangsu Recbio Technology does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Jiangsu Recbio Technology from India?

The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.

Is Jiangsu Recbio Technology a Hong Kong SAR China company, and does that change how it is taxed?

Jiangsu Recbio Technology trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Jiangsu Recbio Technology trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.

Do I have to declare Jiangsu Recbio Technology shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Jiangsu Recbio Technology holding, its cost and its closing value.

How do I sell Jiangsu Recbio Technology and bring the money back to India?

You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.